theophylline and cefaclor anhydrous

theophylline has been researched along with cefaclor anhydrous in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19904 (33.33)18.7374
1990's1 (8.33)18.2507
2000's4 (33.33)29.6817
2010's3 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Andricopulo, AD; Moda, TL; Montanari, CA1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Abate, MA; Hammond, D1
Bachmann, K; Forney, RB; Jauregui, L; Schwartz, J1
Hempenius, J; Holtkamp, A; Jonkman, JH; Schoenmaker, R; van der Boon, WJ2
Derendorf, H; Schifferer, H; Sourgens, H1

Reviews

2 review(s) available for theophylline and cefaclor anhydrous

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Pharmacokinetic profile of cefaclor.
    International journal of clinical pharmacology and therapeutics, 1997, Volume: 35, Issue:9

    Topics: Aged; Antacids; Area Under Curve; Cefaclor; Cephalosporins; Child; Cimetidine; Drug Interactions; Half-Life; Humans; Infant; Renal Insufficiency; Theophylline

1997

Other Studies

10 other study(ies) available for theophylline and cefaclor anhydrous

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Theophylline toxicity, acute illness, and cefaclor administration.
    DICP : the annals of pharmacotherapy, 1989, Volume: 23, Issue:4

    Topics: Acute Disease; Cefaclor; Cephalexin; Child; Drug Interactions; Humans; Male; Theophylline; Virus Diseases

1989
Impact of cefaclor on the pharmacokinetics of theophylline.
    Therapeutic drug monitoring, 1986, Volume: 8, Issue:2

    Topics: Adult; Cefaclor; Cephalexin; Drug Interactions; Female; Half-Life; Humans; Kinetics; Male; Theophylline

1986
Clinical pharmacokinetics of theophylline during co-treatment with cefaclor.
    International journal of clinical pharmacology, therapy, and toxicology, 1986, Volume: 24, Issue:2

    Topics: Adult; Cefaclor; Cephalexin; Drug Interactions; Female; Half-Life; Humans; Kinetics; Male; Theophylline; Time Factors

1986
No effect of cefaclor on theophylline pharmacokinetics.
    European journal of respiratory diseases, 1985, Volume: 66, Issue:1

    Topics: Adult; Cefaclor; Cephalexin; Female; Humans; Kinetics; Male; Theophylline

1985